ArticleSmall methods2026
Engineering Biomimetic Nanoparticle Performance Through Fabrication Method Selection: Turbulent Jet Mixing, Microfluidics, and Extrusion.
Article in Small methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Platelet membrane-coated nanoparticles: Bioengineering principles, quality control, and translational opportunities.APL bioengineering · 2026Review
- Engineering Biomimetic Nanoparticle Performance Through Fabrication Method Selection: Turbulent Jet Mixing, Microfluidics, and Extrusion.Small methods · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Nanoparticle (NP) fabrication has advanced rapidly, driven by the growing role of nanomedicine in targeted drug delivery. Each fabrication strategy offers unique advantages and limitations. Here, we conduct a comparative evaluation of three prominent methods: turbulent jet mixing, microfluidic mixing, and extrusion, for producing biomimetic nanoparticles (BNPs). BNPs are emerging as next-generation drug delivery platforms, combining liposomal biocompatibility with enhanced cellular uptake, prolonged circulation, and selective targeting, achieved by incorporating membrane proteins from source cells into synthetic lipid bilayers to confer cell-mimicking functionality. Using neuron-derived BNPs ("Neurosomes") as a model, we systematically assess physicochemical and biological properties across fabrication methods and their impact on BNP function. Turbulent jet and microfluidic mixing produce BNPs with superior stability, higher membrane protein incorporation, improved batch-to-batch reproducibility, and enhanced targeting, whereas extrusion leads to diminished performance due to shear-induced protein loss. Notably, this study presents the first application of high-resolution LC-MS/MS proteomics to quantitatively compare membrane-associated protein profiles across fabrication methods. These results highlight the critical influence of fabrication techniques on BNP structure and function and provide actionable insights for optimizing production strategies, facilitating the scalable development of targeted nanotherapeutics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.